Life Sciences

No class action status in CA Vioxx lawsuit

Pharma Compliance Alert, May 13, 2009

Los Angeles Superior Court Judge Victoria G. Chaney denied class action status to plaintiffs seeking to sue Merck for its withdrawn painkiller Vioxx.

Chaney said in her ruling that trying plaintiffs’ claims would require an examination of each proposed class member’s medical needs and history, which Merck successfully argued would be unfair, according to a company statement.

Read more about Chaney's decision in the Vioxx lawsuit.

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Medicare & Reimbursement Advisor Weekly

    This electronic newsletter from ePharmaceuticalsT delivers weekly, first-hand reports of marketplace responses to Medicare...

Most Popular

Related Articles